Therapy of other bacterial infections

Dermatologic Therapy

Volumn 17, Issue 6, 2004, Pages 505-512

  Werlinger, Kelly D ^a   Moore, Angela Yen ^a,b,c,d,e  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^d Arlington Center for Dermatology   (United States)

^e NONE   (United States)

Author keywords

Antibacterial agents; Bacterial infections; Infectious skin diseases

Indexed keywords

ACETIC ACID; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFALEXIN; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN; CIPROFLOXACIN; CLINDAMYCIN; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; DICLOXACILLIN; ERYTHROMYCIN; GENTAMICIN; IMIPENEM; LINEZOLID; MACROLIDE; METRONIDAZOLE; NAFCILLIN; OFLOXACIN; PENICILLIN DERIVATIVE; PENICILLIN G; PIPERACILLIN; PSEUDOMONIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFADIAZINE SILVER; UNINDEXED DRUG; VANCOMYCIN;

ACTINOMYCES; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; BACILLUS ANTHRACIS; BACTERIAL INFECTION; BACTERIAL STRAIN; BITE; CARBUNCLE; CELLULITIS; DERMATOLOGY; ECTHYMA; ECTHYMA GANGRENOSUM; ERYSIPELAS; EXTERNAL OTITIS; FOLLICULITIS; FURUNCULOSIS; GRAM NEGATIVE INFECTION; GRAM POSITIVE BACTERIUM; HAEMOPHILUS DUCREYI; HUMAN; IMPETIGO; MENINGOCOCCEMIA; NECROTIZING FASCIITIS; NEISSERIA; NOCARDIA; NONHUMAN; PARONYCHIA; PASTEURELLA MULTOCIDA; PSEUDOMONAS; REVIEW; SEXUALLY TRANSMITTED DISEASE; SKIN INFECTION; STAPHYLOCOCCUS; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS; STREPTOCOCCUS INFECTION; SYCOSIS BARBAE; SYPHILIS; TOXIC EPIDERMAL NECROLYSIS; TREPONEMA PALLIDUM; ULCUS MOLLE; VIBRIO VULNIFICUS; YERSINIA PESTIS;

ANIMALS; ANTI-BACTERIAL AGENTS; HUMANS; SEXUALLY TRANSMITTED DISEASES, BACTERIAL; SKIN DISEASES, BACTERIAL;

EID: 10644247617     PISSN: 13960296     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1396-0296.2004.04053.x     Document Type: Review

References (39)

1. Schweiger ES, Weinberg JM. Novel antibacterial agents for skin and skin structure infections. J Am Acad Dermatol 2004: 50: 331-340.
2. Habif TP. Clinical dermatology: a color guide to diagnosis and therapy. 4th edn. New York: Mosby, 2004.
3. Kielhofner MA, Brown B, Dall L. Influence of underlying disease process on the utility of cellulitis needle aspirates. Arch Intern Med 1988: 11: 2451-2452.
4. Fisher RG, Benjamin DK Jr. Facial cellulitis in childhood: a changing spectrum. South Med J 2002: 95: 672-674.
5. Broome CV, Mortimer EA, Katz SL, Fleming DW, Hightower AW. Use of chemoprophylaxis to prevent the spread of hemophilus influenza B in day-care facilities. N Engl J Med 1987: 316: 1226-1228.
6. Noel LP, Clarke WN, MacDonald N. Clinical management of orbital cellulitis in children. Can J Ophthalmol 1990:25:11-16.
7. Rehder PA, Eliezer ET, Lane AT. Perianal cellulitis. cutaneous group A streptococcal disease. Arch Dermatol 1988: 124: 702-704.
8. Bonnetblanc JM, Bedane C. Erysipelas: recognition and management. Am J Clin Dermatol 2003: 4: 157-163.
9. Sjoblom AC, Eriksson B, Jorup-Ronstrom C, Karkkonen K, Lindqvist M. Antibiotic prophylaxis in recurrent erysipelas. Infection 1993: 21: 390-393.
10. Barton LL, Friedman AD, Portilla MG. Impetigo contagiosa: a comparison of erythromycin and dicloxacillin therapy. Pediatr Dermatol 1988: 5: 88-91.
11. Bisno AL, Cockerill FR 3rd, Bermudez CT. The initial outpatient-physician encounter in group A streptococcal necrotizing fasciitis. Clin Infect Dis 2000 August: 31: 607-608.
12. Urschel JD. Necrotizing soft tissue infections. Postgrad Med J 1999: 75: 645-649.
13. Raz R, Miron D, Colodner R, Staler Z, Samara Z, Keness Y. A 1 year trial of nasal mupirocin in the prevention of recurrent staphylococcal nasal colonization and skin infection. Arch Intern Med 1996: 156: 1109-1112.
14. Liera JL, Levy RC. Treatment of cutaneous abscess: a double-blind clinical study. Ann Emerg Med 1985: 14: 15-19.
15. Dahl MV. Strategies for the management of recurrent furunculosis. South Med J 1987: 80: 352-356.
16. Lyon M, Doehring MC. Blistering distal dactylitis: a case series in children under nine months of age. J Emerg Med 2004: 26: 421-423.
17. Canales FL, Newmeyer WL 3rd, Kilgore ES Jr. The treatment of felons and paronychias. Hand Clin 1989: 5: 515-523.
18. van Balen FA, Smit WM, Zuithoff NP, Verheij TJ. Clinical efficacy of three common treatments in acute otitis externa in primary care: randomized controlled trial. BMJ 2003: 327: 1201-1205.
19. Martel J, Duclos JY, Darrouzet V, Guyot M, Bebear JP. Malignant or necrotizing otitis externa: experience in 22 cases. Ann Otolaryngol Chir Cervicofac 2000: 117: 291.
20. King DF, King LA. Importance of debridement in the treatment of gram-negative bacterial toe web infection. J Am Acad Dermatol 1986: 14: 278-279.
21. Milner SM. Acetic acid to treat Pseudomonas aeruginosa in superficial wounds and burns. Lancet 1992: 340: 61.
22. Aste N, Atzori L, Zucca M, Pau M, Biggio P. Gram-negative bacterial toe web infection: a survey of 123 cases from the district of Cagliari, Italy. J Am Acad Dermatol 2001: 45: 537-541.
23. Bodey GP, Jadeja L, Elting L. Pseudomonas bacteremia. Retrospective analysis of 410 episodes. Arch Intern Med 1985: 145: 1621-1629.
24. Greene SL, Su WP, Muller SA. Ecthyma gangrenosum: report of clinical, histopathologic, and bacteriologic aspects of eight cases. J Am Acad Dermatol 1984: 11: 781-787.
25. Marzouk O, Thomson AP, Sills JA, Hart CA, Harris F. Features and outcome in meningococcal disease presenting with maculopapular rash. Arch Dis Child 1991: 66: 485-487.
26. Ramesh V, Mukherjee A, Chandra M, et al. Clinical, histopathologic and immunologic features of cutaneous lesions in acute meningococcaemia. Indian J Med Res 1990: 91: 27-32.
27. Tapsall J. Current concepts in the management of gonorrhea. Expert Opin Pharmacother 2002: 3: 147-157.
28. Stephenson J. Rise in drug-resistant gonorrhea cases spurs new treatment advice for gay, bisexual men. JAMA 2004: 291: 2420.
29. Centers for Disease Control and Prevention. Sexually-transmitted diseases treatment guidelines 2002. MMWR Recomm Rep 2002: 51: 1-78.
30. Centers for Disease Control and Prevention. Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001. MMWR 2001: 50: 909-919.
31. Inglesby TV, Dennis DT, Henderson DA, et al. Plague as a biological weapon: medical and public health management. JAMA 2000: 283: 2281-2290.
32. Eron LJ. Targeting lurking pathogens in acute traumatic and chronic wounds. J Emerg Med 1999: 17: 189-195.
33. Talan DA, Abrahamian FM, Moran GJ, Citron DM, Tan JO, Goldstein EJC. Clinical presentation and bacteriologic analysis of infected human bites in patients presenting to emergency departments. Am J Emerg Med 2003: 37: 1481-1489.
34. Broder J, Jerrard D, Olshaker J, Witting M. Low risk of infection in selected human bites treated without antibiotics. Am J Emerg Medical 2004: 22: 10-3.
35. Ulusarac O, Carter E. Varied clinical presentations of Vibrio vulniflcus infections: a report of four unusual cases and review of the literature. South Medical J 2004: 97: 163-168.
36. Holmberg K, Nord CE, Dornbusch K. Antimicrobial in vitro susceptibility Actinomyces israelii and Arachnid propionica. Scand J Infect Dis 1980: 9: 40-5.
37. Klontz KC, Lieb S, Schreiber M, Janowski HT, Baldy LM, Gunn RA. Syndromes of Vibrio vulniflcus infections, clinical and epidemiologic features in Florida cases, 1981-1987. Ann Intern Med. 1988 Aug 15: 109(4): 318-23.
38. Curry WA. Human nocardiosis: a clinical review with selected case reports. Arch Intern Medical 1980: 140: 818-26.
39. Sadick NS. Current aspects of bacterial infections of the skin. Dermatol Clin 1997: 15: 341-349.